Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle.

Inactivated injectable vaccine indicated for the active immunisation against BTV-3 reduces viraemia, prevents mortality and reduces the clinical signs of in sheep and reduces viraemia in cattle.

New vaccine is indicated for the active immunisation of sheep and cattle against bluetongue virus serotype 3 (BTV-3).

Extent of market, which employs around 30,000 in Europe, revealed at conference ahead of a wider report due to be published before end of the year.

Vita Animal Health has upgraded Omnicardio Plus to include astaxanthin, an antioxidant that outperforms the previously used coenzyme Q10.

Nutraotic is a new line of “high-strength ear cleaning products” to address common health issues in pets.

Company announces new and improved formulation designed for small and toy dogs of all ages – neutered or entire.

Bovilis Cryptium from MSD is first vaccine proven to protect calves from the start of colostrum feeding against the highly infectious parasite behind the gastrointetinal disease.

Corticosteroid-only Cortotic aims to tackle clinical signs of most frequently recorded disorder in primary veterinary practice.

Ceva Animal Health confirms UK supplies of its enzootic abortion vaccines for ewes are unlikely to be available for several more weeks because of manufacturing issues.

Aura Veterinary in Surrey and Arthrex Vet Systems say they are aiming to transform animal care in veterinary oncology and soft tissue surgery.

Poll of farmers at ScotSheep also shows 86% had heard of ovine Johne’s disease, but only 54% were considering testing.

Company behind Vetoryl launches treatment and monitoring technology to aid owners.

Ceva warns vets and farmers that a vaccine batch failure in the manufacturing process will mean a gap in supply of Cevac Chlamydia from June to August.